Fresh from the biotech pipeline: FDA approvals settle in 2024, but what next?
Nature Biotechnology, Published online: 2src January 2src25; doi:1src.1src38/s41587-src25-src2555-6After two volatile years, FDA approvals in 2src24 settled closer to their 1src-year average. Will nominated commissioner Marty Makary shake things up, or maintain a steady ship…
Nature Biotechnology, Published online: 2src January 2src25; doi:1src.1src38/s41587-src25-src2555-6After two volatile years, FDA approvals in 2src24 settled closer to their 1src-year average. Will nominated commissioner Marty Makary shake things up, or maintain a steady ship…
Read More
About Author
